FDA Inspection
Genzyme FlandersGenzyme Flanders – FDA Inspection, Nov 7, 2025
Record Details
This FDA Inspection record concerns Genzyme Flanders, with an inspection on November 7, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · b4015d67-0c1d-400c-ab34-b92d02b861be
Inspection Facts
- Inspection number
- 1290964
- FDA center
- Biologics
Other FDA inspections of Genzyme Flanders
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 15, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2018 | Not classified | Office of Inspections and Investigations | |
| March 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Genzyme Flanders
- FDA Inspection 1165725 - 2022-02-15
- FDA Inspection 1077100 - 2018-09-28
- FDA Inspection 1049261 - 2018-03-23
- FDA Inspection 983432 - 2016-08-30
- FDA Inspection 975606 - 2016-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.